Novartis, Novo sue Bayer over patent

Novartis and Novo Nordisk are ganging up on Bayer, alleging that the German company's hemophilia treatment Kogenate infringes on one of their joint patents. In a statement, Bayer said it would "vigorously defend itself" against the complaint, and that it doesn't believe it has overstepped the bounds of any patents. The company's stock fell on the news. Meanwhile, other news reports said the suit, filed in federal court in Texas, names Wyeth as well. The New Jersey-based firm has not yet commented.

- see Bayer's release
- read the article at CNN Money
- check out reports of the Wyeth connection at CNN Money

Launch Readiness

Optimize cross-functional collaboration and engage with key stakeholders for the successful launch of a product

Join the Launch Readiness for Medical Affairs & Communications Teams Summit to learn best practices in taking a structured approach to enhance medical affairs activities surrounding a launch and increase knowledge and communication with thought leaders.